DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING UPLC–PDA METHOD FOR SIMULTANEOUS DETERMINATION OF MIRDAMETINIB AND ITS SPECIFIED IMPURITIES
A rapid, sensitive, and reliable reversed-phase UPLC–PDA method was developed and validated for the simultaneous determination of Mirdametinib and its three process-related impurities (Mirdametinib Impurity-1, Impurity-2, and Impurity-3) in pharmaceutical formulations. Chromatographic separation was achieved using a BE...